Login / Signup

Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder.

Mahmoud S AbdallahAhmed N RamadanHend Omara-RedaNoha O MansourMohamed A ElsokaryHozaifa K ElsawahShimaa Abdelsattar ZakiHend E Abo MansourEsraa M Mosalam
Published in: CNS neuroscience & therapeutics (2021)
CLS is safe and effective short-term adjunctive therapy in patients with MDD with no other comorbid conditions. Trial registration ID:NCT04069819.
Keyphrases